Scarica l'app Stockscreener
0.85
8.63%
0.0675
Dopo l'orario di chiusura:
.85
Estrella Immunopharma Inc Borsa (ESLA) Ultime notizie
First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas - CGTLive™
Estrella Immunopharma Inc (ESLA) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Stocks to Watch: Wynn Resorts, Estrella Immunopharma, Amazon.com - MarketWatch
Stocks to Watch : Wynn Resorts, Estrella Immunopharma, Amazon.com - Marketscreener.com
BeyondSpring (BYSI) Stock Surges 6.83% Amid High Volume Trading - GuruFocus.com
Estrella Immunopharma Shares Rise on Lymphoma Patient's Treatment Response - MarketWatch
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS - Business Wire
vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary - Benzinga
EXTR INVESTOR UPDATE: Suffer Losses on Your Extreme Networks, Inc. Investment? Contact BFA Law by October 15 about Pending Class Action Lawsuit (Nasdaq:EXTR) - ForexTV.com
Arizona State Retirement System Has $78,000 Stock Holdings in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) - Defense World
Shareholders that lost money on Extreme Networks, Inc. (EXTR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More - ForexTV.com
Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World
Kessler Topaz Meltzer & Check, LLP Reminds Investors of - GlobeNewswire
Extra Storage rises on Jefferies upgrade - XM
Debt-Free Multibagger Stock Hit 18 Consecutive Upper Circuits & 52-Week Highs: Will the Rally Come to a Halt? - Dalal Street Investment Journal
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Extreme Networks, Inc.EXTR - PR Newswire
Extreme Networks (EXTR) Tumbled 18% After Guiding For - GlobeNewswire
Clene (NASDAQ:CLNN) Stock Quotes, Forecast and News Summary - Benzinga
The Psychology of Extreme Networks Inc. Inc. (EXTR) Price Performance: Understanding Market Sentiment - The InvestChronicle
Estrella Immunopharma Welcomes New Chairperson, Expands Board - TipRanks
Uptake of Nononcology Gene Therapy Remains Slow in Hematology - CGTLive™
Estrella Immunopharma appoints new chairperson to board - Investing.com India
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member - 01Net
ESLAWEstrella Immunopharma, Inc. Warrant Latest Stock News & Market Updates - StockTitan
Estrella Immunopharma, Inc. (NASDAQ:ESLA) Sees Large Growth in Short Interest - MarketBeat
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% - MSN
Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas Doses First Patient - CGTLive™
Estrella Immunopharma, Inc. (NASDAQ:ESLA) Short Interest Up 8.5% in July - MarketBeat
ESLA’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% | Stock Market News - Mint
Keppel REIT (OTCMKTS:KREVF) Sees Large Growth in Short Interest - American Banking and Market News
Apple Inc. (NASDAQ:AAPL) Shares Acquired by Saxon Interests Inc. - American Banking and Market News
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 24.9% in June - American Banking and Market News
Estrella Immunopharma, Inc. (NASDAQ:ESLA) Short Interest Up 60.0% in June - MarketBeat
Estrella Immunopharma, Inc. (NASDAQ:ESLA) Short Interest Update - Defense World
Around the Helix: Cell and Gene Therapy Company Updates – July 10, 2024 - CGTLive™
Estrella Immunopharma streamlines operations with subsidiary merger By Investing.com - Investing.com India
ZUU Co. Ltd. executives purchase Pono Capital two shares worth $390 By Investing.com - Investing.com
Maersk exits DB Schenker bid; Citi reaffirms sell rating on stock By Investing.com - Investing.com
Entergy appoints new directors across subsidiaries By Investing.com - Investing.com UK
AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga
Halliburton (NYSE:HAL) Receives Average Rating of “Buy” from Analysts - Defense World
iBio, Inc. (NYSEAMERICAN:IBIO) Sees Significant Growth in Short Interest - Defense World
Estrella Immunopharma, Inc. (NASDAQ:ESLA) Sees Significant Growth in Short Interest - Defense World
Head-To-Head Survey: Mynd.ai (OTCMKTS:MYND) & New Oriental Education & Technology Group (NYSE:EDU) - Defense World
We Think Estrella Immunopharma (NASDAQ:ESLA) Can Afford To Drive Business Growth - Yahoo Movies UK
Omid Hamid, MD, on Clinic Experience With TIL vs CAR-T Therapy Administration - CGTLive™
Ratio Analysis: Unpacking Estrella Immunopharma Inc (ESLA)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Honest Company, Inc. (NASDAQ:HNST) Sees Significant Decline in Short Interest - Defense World
LakeShore Biopharma (NASDAQ:LSB) Stock Quotes, Forecast and News Summary - Benzinga
ESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024 - InvestorPlace
Estrella Immunopharma Unveils Updated Investor Presentation - TipRanks
Uttam Rao, MD, MBA, on Comparing Conditioning Regimens for CAR-T - CGTLive™
Morning SPAC News Roundup: January 31, 2024｜SPACInsider - SPACInsider
Allogeneic CD22 CAR Cleared for First-in-Human Trial in B-Cell Malignancies - CGTLive™
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances - InvestorPlace
Estrella Immunopharma (NASDAQ:ESLA) Stock Quotes, Forecast and News Summary - Benzinga
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):